With more people surviving cancer, programs to help them stay healthy after treatment are growing, but are still concentrated at large, expensive academic centers.
Tempus, Eric Lefkofsky's cancer-data company, is getting a $70 million boost from some familiar partners: New Enterprise Associates and Revolution Growth. The two Washington, D.C.-area venture funds led a new round of financing that brings the total outside investments in Tempus to $130 million.
Singleton oversaw the growth of the Falls Church, Va.-based system from $500 million to $3.3 billion in revenue. Recently, he was involved in efforts to bolster Inova's position as a national leader in precision medicine and cancer research.
The cancer community is deploying advanced-practice providers to help address a shortage of services. But integrating them into a practice isn't easy.
Plans are moving forward for a new cancer care facility in Detroit. A groundbreaking event takes place Tuesday for the Brigitte Harris Cancer Pavilion, which will be part of the Henry Ford Cancer Institute.
In an interview with Modern Healthcare this week, Soon-Shiong said his company's new cancer therapy gets to the root causes of the disease. He also said that recent reports questioning the success of his company's therapies are based on "ignorance," which he "ignores."
Most doctors did not discuss the cost of cancer treatment with patients, spent less than two minutes on it when they did, and usually did so only after patients brought it up, a study that taped hundreds of visits at several large hospitals finds.
Charred food may be one of the latest fads at fashionable restaurants—at least according to the New York Times food section—but there seems to be a dark side to this trend.
The U.S. cancer mortality rate, in steady decline for over three decades, still takes a higher toll on African Americans. Regional disparities persist, too, with some areas of the country seeing worsening cancer mortality rates.
A malaria drug is doing something it's never done before: treat brain cancer.
Cancer deaths have declined in the U.S. over the past three decades, but mortality rates can vary greatly depending on the county where you live. Researchers say that information could better inform treatment and prevention efforts in certain communities.
Dr. Gilbert Padula is Summa Health System's new medical director for the Summa Health Cancer Institute, starting Jan. 30.